Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Omics Studies of Tumor Cells under Microgravity Conditions. | Int J Mol Sci | 2024 | 38255998 | PubTator, text mining | PubMed |
| Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential. | Int J Mol Sci | 2024 | 38255791 | PubTator, text mining | PubMed |
| Deficiency of copper responsive gene stmn4 induces retinal developmental defects. | Cell Biol Toxicol | 2024 | 38252267 | PubTator, text mining | PubMed |
| Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote mitoxantrone resistance in stomach adenocarcinoma. | Mol Biol Rep | 2024 | 38194158 | PubTator, text mining | PubMed |
| Integrated analysis of miRNA-mRNA expression of newly emerging swine H3N2 influenza virus cross-species infection with tree shrews. | Virol J | 2024 | 38178220 | PubTator, text mining | PubMed |
| FAXDC2 inhibits the proliferation and invasion of human liver cancer HepG2 cells. | Exp Ther Med | 2024 | 38125362 | PubTator, text mining | PubMed |
| Novel 2 Gene Signatures Associated With Breast Cancer Proliferation: Insights From Predictive Differential Gene Expression Analysis. | Mod Pathol | 2024 | 38104894 | PubTator, text mining | PubMed |
| Single-cell RNA-seq and single-cell bisulfite-sequencing reveal insights into yak preimplantation embryogenesis. | J Biol Chem | 2024 | 38097189 | PubTator, text mining | PubMed |
| Oncogenic role of FOXM1 in human prostate cancer (Review). | Oncol Rep | 2024 | 38038123 | PubTator, text mining | PubMed |
| Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease. | J Allergy Clin Immunol | 2024 | 37898408 | PubTator, text mining | PubMed |
| Vitamin D3 promotes gastric cancer cell autophagy by mediating p53/AMPK/mTOR signaling. | Front Pharmacol | 2023 | 38259281 | PubTator, text mining | PubMed |
| Embelin: A multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis. | EXCLI J | 2023 | 38234968 | PubTator, text mining | PubMed |
| Drug Discovery Based on Oxygen and Nitrogen (Non-)Heterocyclic Compounds Developed @LAQV-REQUIMTE/Aveiro. | Pharmaceuticals (Basel) | 2023 | 38139794 | PubTator, text mining | PubMed |
Preparation and investigation of a novel combination of Solanum nigrum-loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: in vitro, in vivo, and in silico evaluation. | Front Pharmacol | 2023 | 38125886 | PubTator, text mining | PubMed |
| Methylation analysis by targeted bisulfite sequencing in large for gestational age (LGA) newborns: the LARGAN cohort. | Clin Epigenetics | 2023 | 38093359 | PubTator, text mining | PubMed |
| Fascin actin-bundling protein 1 regulates non-small cell lung cancer progression by influencing the transcription and splicing of tumorigenesis-related genes. | PeerJ | 2023 | 38077434 | PubTator, text mining | PubMed |
| Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. | Int J Mol Sci | 2023 | 38069284 | PubTator, text mining | PubMed |
| A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease. | Exp Hematol Oncol | 2023 | 38041102 | PubTator, text mining | PubMed |
| FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. | Cancer Res Commun | 2023 | 38032106 | PubTator, text mining | PubMed |
| Novel maleic anhydride derivatives: liquid crystalline materials with enhanced mesomorphic and optical characteristics. | Front Chem | 2023 | 38025055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=4